Cambridge, MA, United States of America

Emily Payton Lee

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2018-2021

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Emily Payton Lee: Innovator in Patient Stratification

Introduction

Emily Payton Lee is a prominent inventor based in Cambridge, MA, known for her significant contributions to the field of patient treatment stratification. With a total of three patents to her name, she has made notable advancements in the use of retinoic acid receptor-alpha agonists for patient care.

Latest Patents

Emily's latest patents focus on methods of stratifying patients for treatment with retinoic acid receptor-alpha agonists. These patents describe innovative methods that define cellular populations sensitive to RARA agonists and identify patient populations that will benefit from such treatments. The methods may involve administering RARA agonists to specific patient groups, enhancing the effectiveness of therapeutic interventions.

Career Highlights

Emily Payton Lee is currently employed at Syros Pharmaceuticals, Inc., where she continues to develop her research and innovations in the medical field. Her work is instrumental in advancing personalized medicine and improving patient outcomes through targeted therapies.

Collaborations

Emily collaborates with esteemed colleagues, including Michael Robert McKeown and Christopher Fiore, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Emily Payton Lee's work exemplifies the impact of innovative thinking in the medical field, particularly in patient stratification for treatment. Her contributions are paving the way for more effective and personalized healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…